Podcasts about cardiovascular

In this episode, Dr. Rena Malik, MD is joined by Dr. Mohit Khera for an in-depth discussion about testosterone, erectile dysfunction, and men's overall health. The conversation explores the realities and myths of testosterone therapy, revealing which patients are most likely to benefit from treatment and the importance of evaluating underlying health conditions. Dr. Khera and Dr. Malik review recent clinical trials, address common misconceptions about testosterone's impact on erectile function, and highlight the significant role of lifestyle factors such as weight loss, sleep, and stress reduction in boosting testosterone levels naturally. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00 Testosterone and Erectile Dysfunction 04:05 Major Clinical Trials Overview 08:57 Cardiovascular and Prostate Safety 12:48 Lifestyle Changes and Testosterone 17:29 Stress, Sleep, and Hormonal Health 21:00 Broader Health Impacts of Low Testosterone 25:15 Anabolic Steroids and Estrogen Management Stay connected with Dr. Mohit Khera on social media for daily insights and updates. Don't miss out—follow him now and check out these links! INSTAGRAM - https://www.instagram.com/drmohitkhera/?hl=en X - https://x.com/drmohitkhera?lang=en WEBSITE - https://drmohitkhera.com/ Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, CardioNerds Dr. Gurleen Kaur, Dr. Richard Ferraro, and Dr. Jake Roberts are joined by Cardio-Rheumatology expert, Dr. Monica Mukherjee, to discuss the role of utilizing multimodal imaging for cardiovascular disease risk stratification, monitoring, and management in patients with chronic systemic inflammation. The team delves into the contexts for utilizing advanced imaging to assess systemic inflammation with cardiac involvement, as well as the role of imaging in monitoring various specific cardiovascular complications that may develop due to inflammatory diseases. Audio editing by CardioNerds academy intern, Christiana Dangas. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls - Cardiovascular Multimodality Imaging & Systemic Inflammation Systemic inflammatory diseases are associated with an elevated CVD risk that has significant implications for early detection, risk stratification, and implementation of therapeutic strategies to address these risks and disease-specific complications. As an example, patients with SLE have a 48-fold increased risk for developing ASCVD compared to the general population. They may also develop disease-specific complications, such as pericarditis, that require focused imaging approaches to detect. In addition to increasing the risk for CAD, systemic inflammatory diseases can also result in cardiac complications, including myocardial, pericardial, and valvular involvement. Assessment of these complications requires the use of different imaging techniques, with the modality and serial studies selected based on the suspected disease process involved. In most contexts, echocardiography remains the starting point for evaluating cardiac involvement in systemic inflammatory diseases and can inform the next steps in terms of diagnostic study selection for the assessment of specific cardiac processes. For example, if echocardiography is completed in an SLE patient and demonstrates potential myocardial or pericardial inflammation, the next steps in evaluation may include completing a cardiac MRI for better characterization. While no current guidelines or standards of care directly guide our selection of advanced imaging studies for screening and management of CVD in patients with systemic inflammatory diseases, our understanding of cardiac involvement in these patients continues to improve and will likely lead to future guideline development. Due to the vast heterogeneity of cardiac involvement both across and within different systemic inflammatory diseases, a personalized approach to caring for each individual patient remains central to CVD evaluation and management in these patients. For example, patients with systemic sclerosis and symptoms of shortness of breath may experience these symptoms due to a range of causes. Echocardiography can be a central guiding tool in assessing these patients for potential concerns related to pulmonary hypertension or diastolic dysfunction. Based on the initial echocardiogram, the next steps in evaluation may involve further ischemic evaluation or right heart catheterization, depending on the pathology of concern. Show notes - Cardiovascular Multimodality Imaging & Systemic Inflammation Episode notes drafted by Dr. Jake Roberts. What are the contexts in which we should consider pursuing multimodal cardiac imaging, and are there certain inflammatory disorders associated with systemic inflammation and higher associated CVD risk for which advanced imaging can help guide early intervention? Systemic inflammatory diseases are associated with elevated CVD risk, which has significant implications for early detection, risk stratification, prognostication, and implementation of therapeutic strategies to address CVD risk and complicat...

This week we speak with Professor Vladimiro Vida of U. Padua about a recent ECHSA large scale study assessing surgical outcomes of newborn cardiac surgery in Europe. What trends have become apparent in the past 10 years and why are outcomes generally better overall in this complex patient group? Why have outcomes for single ventricle surgery not improved as much as other newborn surgeries? Is there a relationship between center volume and outcomes? What interventions might result in improvements in outcomes of Norwood palliation? Dr. Vida provides his insights this week. https://doi.org/10.1016/j.athoracsur.2024.07.023

HEALTH NEWS   Effects of High-Intensity Intermittent Training Combined with Asparagus Extract Supplementation on Cardiovascular and Pulmonary Function What 300 grams of ultra-processed food a day does to your diabetes risk New study from landmark trial suggests avocados may play a role in sleep, a key factor in cardiovascular health Longer walks linked to lower risk of chronic low back pain Natural Compound in Fruit and Vegetables Found To Slash Heart Disease and Diabetes Risk Cannabis use linked to doubling in risk of cardiovascular disease death

Board-certified interventional cardiologist, Tansel Turgut MD, will discuss the top 10 myths about cardiovascular disease.

Dr. Louis Perrault, president of the Association of Cardiovascular and Thoracic Surgeons of Quebec

I have mentioned before a program I attend entitled Podapalooza. This quarterly event brings together podcasters, would-be podcasters and people interested in being interviewed by podcasters. This all-day program is quite fun. Each time I go I request interview opportunities to bring people onto Unstoppable Mindset. I never really have a great idea of who I will meet, but everyone I have encountered has proven interesting and intriguing.   This episode we get to meet Dr. Laura Hambley Lovett who I met at Podapalooza 12. I began our episode by asking Laura to tell me a bit about her growing up. We hadn't talked about this before the episode. The first thing she told me was that she was kind of an afterthought child born some 12.5 years after her nearest sibling. Laura grew up curious about many things. She went to University in Calgary. After obtaining her Master's degree she worked for some corporations for a time, but then went back to get her Doctorate in Organization Psychology.   After discussing her life a bit, Dr. Laura and I discussed many subjects including fear, toxic bosses and even something she worked on since around 2005, working remotely. What a visionary Laura was. I like the insights and thoughts Dr. Lovett discusses and I think you will find her thoughts worth hearing.   On top of everything else, Laura is a podcaster. She began her podcast career in 2020. I get to be a guest on her podcast, _Where Work Meets Life_TM, in May of 2025. Be sure to check out her podcast and listen in May to see what we discuss.   Laura is also an author as you will learn. She is working on a book about toxic bosses. This book will be published in January of 2026. She also has written two fiction books that will soon be featured in a television series. She tells us about what is coming.       About the Guest:   Dr. Laura Hambley Lovett is an Organizational Psychologist, Keynote Speaker, Business Leader, Author, and Podcast Host. She is a sought-after thought leader on workplace psychology and career development internationally, with 25 years of experience. Dr. Laura is a thought leader on the future of work and understands the intersection of business and people.     Dr. Laura's areas of expertise include leadership, team, and culture development in organizations, remote/hybrid workplace success, toxic leadership, career development, and mental health/burnout. She holds a Ph.D. in Industrial/Organizational Psychology from the University of Calgary, where she is currently an Adjunct Professor.     As a passionate entrepreneur, Dr. Laura has founded several psychology practices in Canada since 2009, including Canada Career Counselling, Synthesis Psychology, and Work EvOHlution™ which was acquired in 2021.  She runs the widely followed podcast _Where Work Meets Life_TM, which began in 2020.  She speaks with global experts on a variety of topics around thriving humans and organizations, and career fulfillment.     In addition to her businesses, she has published two psychological thrillers, Losing Cadence and Finding Sophie. She hopes to both captivate readers and raise awareness on important topics around mental health and domestic violence.  These books are currently being adapted for a television series.  Dr. Laura received a Canadian Women of Inspiration Award as a Global Influencer in 2018. Ways to connect with Dr. Laura:   Email: Connect@drlaura.live   Website: https://drlaura.live/    LinkedIn: @drlaurahambley/    Keynotes: Keynotes & Speaking Engagements   Podcast: Where Work Meets Life™ Podcast   Author: Books   Newsletter: Subscribe to Newsletter   Youtube: @dr.laurawhereworkmeetslife   Facebook: @Dr.Laura.whereworkmeetslife   Instagram: @dr.laura__   Tik Tok: @drlaura__   X: @DrLaura_   About the Host:   Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog.   Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards.   https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/   accessiBe Links https://accessibe.com/ https://www.youtube.com/c/accessiBe https://www.linkedin.com/company/accessibe/mycompany/ https://www.facebook.com/accessibe/       Thanks for listening!   Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below!   Subscribe to the podcast   If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can subscribe in your favorite podcast app. You can also support our podcast through our tip jar https://tips.pinecast.com/jar/unstoppable-mindset .   Leave us an Apple Podcasts review   Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.       Transcription Notes:     Michael Hingson ** 00:00 Access Cast and accessiBe Initiative presents Unstoppable Mindset. The podcast where inclusion, diversity and the unexpected meet. Hi, I'm Michael Hingson, Chief Vision Officer for accessiBe and the author of the number one New York Times bestselling book, Thunder dog, the story of a blind man, his guide dog and the triumph of trust. Thanks for joining me on my podcast as we explore our own blinding fears of inclusion unacceptance and our resistance to change. We will discover the idea that no matter the situation, or the people we encounter, our own fears, and prejudices often are our strongest barriers to moving forward. The unstoppable mindset podcast is sponsored by accessiBe, that's a c c e s s i capital B e. Visit www.accessibe.com to learn how you can make your website accessible for persons with disabilities. And to help make the internet fully inclusive by the year 2025. Glad you dropped by we're happy to meet you and to have you here with us.     Michael Hingson ** 01:21 Well, hi everyone, wherever you happen to be, I want to welcome you to another episode of unstoppable mindset. I am your host, Mike hingson, and we have, I think, an interesting guest today. She's an organizational psychologist. She is a keynote speaker, and she even does a podcast I met Dr Laura through a function that we've talked about before on this podcast, Pata palooza. We met at pollooza 12. So that goes back to January. I think Dr Laura is an organizational psychologist. As I said, she's a keynote speaker. She runs a podcast. She's written books, and I think you've, if I'm not mistaken, have written two fiction books, among other things, but we'll get to all that. But Laura, I want to welcome you to unstoppable mindset. And thank you very much for being here.   Dr. Laura Hambley Lovett ** 02:12 Well, thank you for having me, Michael. I really think the world of you and admire your spirit, and I'm just honored to be here speaking with you today. Well,   Michael Hingson ** 02:22 as I tell people when they come on the podcast, we do have one hard and fast rule, and that is, you're supposed to have fun. So if you can't have fun, forget about   Dr. Laura Hambley Lovett ** 02:30 it. Okay, alright, I'm willing to There   Michael Hingson ** 02:34 you go see you gotta have a little bit of fun. Well, why don't we start as I love to do with a lot of folks tell us kind of about the early Laura, growing up and all that, and kind of how you got where you are, if you will. Oh, my goodness, I know that opens up a lot of options.   Dr. Laura Hambley Lovett ** 02:52 I was an afterthought child. I was the sixth child of a Catholic mother who had five children in a row, and had me 12 years later, unplanned, same parents, but all my siblings are 12 to 19 years older than me, so I was caught between generations. I always wanted to be older than I was, and I felt, you know, I was almost missing out on the things that were going on before me. But then I had all these nieces and nephews that came into the world where I was the leader of the pack. So my niece, who's next in line to me, is only three years younger, so it just it makes for an interesting dynamic growing up where you're the baby but you're also the leader. Well,   Michael Hingson ** 03:39 lot of advantages there, though I would think,   Dr. Laura Hambley Lovett ** 03:42 Oh yeah, it taught me a lot about leadership. It taught me about followership. It taught me about life and learning the lessons from my older siblings of what you know, they were going through and what I wanted to be like when I grew up.   Michael Hingson ** 03:58 So, so what kind of things did you learn from all of that? And you know, what did, what did they teach you, and what did they think of you, all of your older siblings? Oh, they loved me. I was, I bet they were. Yeah, you were the baby sister.   Dr. Laura Hambley Lovett ** 04:13 But I should add my mom was mentally ill, so her mental illness got worse after having me, I think, and I know this about postpartum, as you get older and postpartum hits, it can get worse later on and and she suffered with a lot of mental health challenges, and I would say that that was the most challenging part of growing up for me.   Michael Hingson ** 04:42 Did she ever get over that? Or?   Dr. Laura Hambley Lovett ** 04:45 No, we just, I mean, it had its ups and downs. So when times were good, she was great, she was generous, she was loving. She was a provider, a caretaker. She had stayed at home her whole life, so she was the stay at home mom, where you'd come home from school. And there'd be hot, baked cookies and stuff, you know, she would really nurture that way. But then when she had her lows, because it was almost a bipolar situation, I would, I would say it was undiagnosed. I mean, we never got a formal diagnosis, but she had more than one psychotic break that ended her in the hospital. But I would say when she was down, she would, you know, run away for a few days and stay in another city, or have a complete meltdown and become really angry and aggressive. And, I mean, it was really unpredictable. And my father was just like a rock, just really stable and a loving influence and an entrepreneur like I am, so that, you know, he really helped balance things out, but it was hard on him as well,   Michael Hingson ** 05:48 I'll bet. Yeah, that's never easy. Is she still with us, or is she passed?   Dr. Laura Hambley Lovett ** 05:53 No, she got dementia and she passed. The dementia was about 12 years of, you know, turning into a baby. It's so sad that over 12 years, we just she lost her mind completely, and she died in 2021 and it was hard. I mean, I felt like, oh, man, you know, that was hard. I you know, as much as it was difficult with her and the dementia was difficult. I mean, she was my mother, and, yeah, it was a big loss for me. And I lost my father at age 21 and that was really hard. It was a very sudden with an aneurysm. And so that was in 1997 so I've been a long time without parents in my life.   Michael Hingson ** 06:30 Wow. Well, I know what you mean. My father, in this is his opinion, contracted some sort of a spore in Africa during World War Two, and it manifested itself by him losing, I think it was white blood cells later in his life, and had to have regular transfusions. And eventually he passed in 1984 and my belief is, although they classified it as congestive heart failure, he had enough other diseases or things that happened to him in the couple of years before he passed. I think it was actually HIV that he died from, because at that time, they still didn't understand about tainted blood, right? And so he got transfusions that probably were blood that that was a problem, although, you know, I can't prove that, and don't know it, but that's just kind of my opinion.   Dr. Laura Hambley Lovett ** 07:34 Oh, I'm so sorry to hear that, Michael, that is so, so sad.   Michael Hingson ** 07:38 Yeah. And then my mom was a smoker most of her life, and she fell in 1987 and broke her hip, and they discovered that she also had some some cancer. But anyway, while she was in the hospital recovering from the broken hip, they were going to do some surgery to deal with the cancer, but she ended up having a stroke and a heart attack, and she passed away. So Oh, my God. I lost my mom in 1987   Dr. Laura Hambley Lovett ** 08:04 and you know, you were young. Well,   Michael Hingson ** 08:08 I was, I was 37 when she died. So still, I missed them both, even today, but I I had them for a while, and then my brother, I had until 2015 and then he passed from cancer. So it happens, and I got married in 1982 to my wife, Karen, who was in a wheelchair her whole life, and she passed in 2022 so we were married 40 years. So lots of memories. And as I love to tell people all the time, I got to continue to be a good kid, because I'm being monitored from somewhere, and if I misbehave, I know I'm going to hear about it. So,   Dr. Laura Hambley Lovett ** 08:49 you know, well, that's a beautiful, long marriage that the two of you had   Michael Hingson ** 08:55 was and lots of memories, which is the important things. And I was blessed that with September 11 and so on, and having written thunder dog, the original book that I wrote about the World Trade Center and my life, it was published in 2011 and I was even reading part of it again today, because I spoke at a book club this morning, it just brings back lots of wonderful memories with Karen, and I just can't in any way argue with the fact that we did have a great 40 years. So no regrets.   Dr. Laura Hambley Lovett ** 09:26 Wow, 40 years.   Michael Hingson ** 09:30 Yeah. So, you know, it worked out well and so very happy. And I know that, as I said, I'm being monitored, so I I don't even chase the girls. I'm a good kid. Chris, I would point out none of them have chased me either. So, you know,   Dr. Laura Hambley Lovett ** 09:49 I love your humor. It's so awesome. So we gotta laugh, Mark, because the world's really tricky right now. Oh gosh, isn't it? It's very tricky. And I'd love to talk. About that today a bit, because I'm just having a lot of thoughts about it and a lot of messages I want to get across being well, you are well psychologist and a thought leader and very spiritual and just trying to make a difference, because it's very tricky.   Michael Hingson ** 10:16 So how did you get into psychology and all that. So you grew up, obviously, you went to college and tell me about that and how you ended up getting into the whole issue of psychology and the things that you do. Well,   Dr. Laura Hambley Lovett ** 10:30 I think being the youngest, I was always curious about human dynamics in my family and the siblings and all the dynamics that were going on, and I was an observer of all of that. And then with my mother and just trying to understand the human psyche and the human condition. And I was a natural born helper. I always wanted to help people, empathetic, very sensitive kid, highly sensitive person. So then when I went into psycho to university. We University. We call it up here for an undergrad degree, I actually didn't know what I wanted to do. I was a musician as well. I was teaching music throughout high school, flute and piano. I had a studio and a lot of students. And thought, well, maybe do I want to do a music degree? Or, Oh, maybe I should go into the family business of water treatment and water filtration that my father started for cities, and go in and do that and get a chemical engineering degree. Not really interested in that, though, no. And then just kind of stumbled my way through first year. And then I was really lost. And then I came across career counseling. And I thought, Okay, this is going to help me. And it did. And psychology lit up like a light bulb. I had taken the intro to psych course, which is more of a hodgepodge mix of topics. I'm like, yeah, and then, but when I looked at the second year courses in the third year and personality and abnormal psych and clinical psych and all of that. I thought, Oh, I found my place. This is juicy. This is interesting. And I want to help people. Is   Michael Hingson ** 12:09 this to say you fit right in when you were studying Abnormal Psychology? Just checking,   Dr. Laura Hambley Lovett ** 12:14 yeah, probably okay. I actually didn't go down the clinical psych route, which is where it's the clinical psych and the psychiatrists that tackle more of the personality disorders. So I went into counseling psych, which is the worried well. We call it the worried well. So people like you and I who are going through life, experiencing the various curve balls that life has to offer, and I know you've been through more than your fair share, but it's helping people get through the curve balls. And I specialized in career, I ended up saying people spend most of their waking lives, you know, working or thinking about work as part of their identity. So I specialized in career development psychology in my master's degree.   Michael Hingson ** 13:01 Yeah, well, that's, that's certainly, probably was easier than flute and piano. You couldn't do both of those at the same time.   Dr. Laura Hambley Lovett ** 13:07 I ended up having to, yeah, it became too much. I tried to for a while.   Michael Hingson ** 13:13 Yeah, you can play the flute or the piano, but kind of hard to do both at the same time. Oh,   Dr. Laura Hambley Lovett ** 13:18 at the same time, yeah, unless you play with your toes, which I've seen people actually people do that, yeah, do Yeah. There's this one speaker in our national speakers group, and he he does a lot with his toes, like I remember him playing the drums with his toes at his last keynote. So I was just amazed. So horn with no arms and does everything with his feet. So I bet he could do some piano too. There you go.   Michael Hingson ** 13:49 But then, of course, having no arms and he would also have a problem doing piano at the same time. But, you know, that's okay, but still, so you went into to psychology, which I find is a is a fascinating subject. Anyway, my interest was always in the physical sciences, so I got my master's degree in physics, although I did take a couple of psychology courses, and I enjoyed it. I remember the basic intro to psych, which was a lot of fun, and she's had a real hodgepodge, but still it was fascinating. Because I always was interested in why people behave the way they do, and how people behave the way they do, which is probably why I didn't go into theoretical physics, in a sense. But still it was and is very interesting to see how people behave, but you went off and got your masters, and then you also got a PhD along the line, huh?   Dr. Laura Hambley Lovett ** 14:47 Yeah, that was interesting. I did the Masters, and then I always did things a little differently. Michael, so all of my peers went on to become registered psychologists, which, which means you have. To go through a registration process, and instead, I got pulled into a.com company. We called them dot coms at the time, because in 1999 when I started with a.com It was a big thing. I mean, it was exciting, right? It was and it was a career development related.com that had a head office in New York City, and I ended up leading a team here in Calgary, and we were creating these technologies around helping people assess their passions, their interests, their skills, and then link to careers. We had about 900 careers in our database, and then linking people to educational programs to get them towards those careers. So I remember coming up a lot of times to Rutgers University and places like that, and going to New York City and dealing with that whole arena. So I was, you know, from a young age, I'd say I was too young to rent a car when I flew there, but I had a team of about 15 people that I oversaw, and it was great experience for me at an early age of, okay, you know, there's a lot I'm learning a lot here, because I really wasn't trained in Business and Management at that time, right?   Michael Hingson ** 16:17 But you But you did it.   Dr. Laura Hambley Lovett ** 16:20 I did it, yeah, I did it. And then I ended up working for another consulting firm that brought me into a whole bunch of organizations working on their competency models. So I did a lot of time in the Silicon Valley, working in different companies like Cisco, and I was just in this whole elaborate web of Okay. Organizations are quite interesting. They're almost like families, because they have a lot of dynamics there. It's interesting. And you can make a difference, and you can help the organization, the people in the workplace, you know, grow and thrive and develop. And I'm okay, you know, this is interesting, too. I like this. And then at that time, I knew I wanted to do a doctorate, and I discovered that organizational Psych was what I wanted to do, because it's the perfect blend of business and psychology. Because I'm a serial entrepreneur, by the way, so entrepreneurship, psychology, business, kind of the best of both worlds. Okay, I'm going to do that, so that's what I did.   Michael Hingson ** 17:24 That certainly is kind of cool. So when did you end up getting your doctorate?   Dr. Laura Hambley Lovett ** 17:28 I finished that in 2005   Michael Hingson ** 17:31 okay, were you working while you were doing that? Or did you just go back to school full   Dr. Laura Hambley Lovett ** 17:36 time? I had to go back to school because the program was very heavy. It was a program where you could not work full time during it. I still worked part time during it. I was working hard because I was registering as a psychologist at the same time, I knew I wanted to register and become a psychologist, and I knew I wanted to get that doctorate, and there were times when I almost stepped away, especially at the beginning of it, because when you're out in the real world, and then you go back into academia, it's just such a narrow How do I explain this? How does this, how is this relevant? You know, all these journal articles and this really esoteric, granular research on some little itty, itty bitty thing. And I just really struggled. But then I said, So I met with someone I remember, and she she said, Laura, it's like a car. When you buy a car, you can choose your own car seats and color, and you know, the bells and whistles of your car, and you can do that for the doctorate. And I said, Okay, I'm going to make the doctorate mine, and I'm going to specialize in a topic that I can see being a topic that the world of work will face in the future. So I specialized in remote leadership, and how you lead a team when they're not working in the same office, and how you lead and inspire people who are working from home. And that whole notion of distributed work, which ended up becoming a hot topic in the pandemic. I was, I was 20 years, 15 years ahead of the game. Yeah. Well, that,   Michael Hingson ** 19:09 of course, brings up the question of the whole issue of remote work and stuff during the pandemic and afterward. What do you what do you think has been the benefit of the whole concept of remote work. What did people learn because of the pandemic, and are they forgetting it, or are they still remembering it and allowing people to to work at home? And I ask that because I know in this country, our illustrious president is demanding that everybody go back to work, and a lot of companies are buying into that as well. And my thought has always been, why should we worry about where a person works, whether it's remote or in an actual office, so long as they get the work? Done, but that seems to, politically not be the way what people want to think of it today.   Dr. Laura Hambley Lovett ** 20:06 Yeah, it's, I mean, I have a lot to say on it, and I have years and years of data and research that supports the notion that it's not a one size fits all, and a blend tends to be the best answer. So if you want to preserve the culture and the collaboration, but yet you want to have people have the flexibility and autonomy and such, which is the best of both worlds. Because you're running a workplace, you're not running a daycare where you need to babysit people, and if you need to babysit people, you're hiring the wrong people. So I would say I'm a biggest fan of hybrid. I think remote works in some context, I think bringing everyone back full time to an office is very, very old school command and control, leadership, old school command and control will not work. You know, when you're trying to retain talent, when it's an employer's market, yes, you'll get away with it. But when it goes back to an employee's market. Watch out, because your generation Z's are going to be leaving in droves to the companies that offer flexibility and autonomy, same with some of your millennials, for sure, and even my generation X. I mean, we really value, you know, a lot of us want to have hybrids and want to be trusted and not be in a car for 10 to 20 hours a week commuting? Yeah? So,   Michael Hingson ** 21:27 yeah, I know I hear you, and from the baby boomer era, you know, I I think there's value in being in an office that is, I think that having time to interact and know colleagues and so on is important. But that doesn't mean that you have to do it every day, all day. I know many times well. I worked for a company for eight years. The last year was in New York because they wanted me to go to New York City and open an office for them, but I went to the office every day, and I was actually the first person in the office, because I was selling to the east coast from the west coast. So I opened the office and was on the phone by 6am in the morning, Pacific Time, and I know that I got so much more done in the first two to three hours, while everyone else was slowly filtering in, and then we got diverted by one thing or another, and people would gossip and so on. Although I still tried to do a lot of work, nevertheless, it got to be a little bit more of a challenge to get as much done, because now everybody was in and they wanted to visit, or whatever the case happens to be, and I think there's value in visiting, but I think from a working standpoint, if I'd been able to do that at home, at least part of the time, probably even more would have been accomplished. But I think there's value also in spending some time in the office, because people do need to learn to interact and know and trust each other, and you're not going to learn to trust if you don't get to know the other people.   Dr. Laura Hambley Lovett ** 23:08 Yeah, totally. I agree with you 100% and I know from it. I on my own podcast I had the founder of four day work week global, the four day work movement. I did four episodes on that topic, and yeah, people are not productive eight hours a day. I'll tell you that. Yeah, yeah. So just because you're bringing them into an office and forcing them to come in, you're not gonna it doesn't necessarily mean more productivity. There's so much that goes into productivity, apart from presenteeism, yeah,   Michael Hingson ** 23:45 yeah, I hear what you're saying, and I think there's, there's merit in that. I think that even when you're working at home, there are rules, and there you're still expected to do work, but there's, I think, room for both. And I think that the pandemic taught us that, but I'm wondering if we're forgetting it.   Dr. Laura Hambley Lovett ** 24:06 Oh yeah, that's the human condition. We forget, right? We, we forget. We it's almost I envision an icy ski slope. I'm a skier, you know, being up here in Canada and the Rocky Mountains, but it's a ski slope, and you walk up a few steps, and then you slide back so easily, because it's icy, right? Like you gotta just be aware that we slide back easily. We need to be intentional and stay on top of the why behind certain decisions, because the pendulum swings back so far so easily. And I mean, women's issues are one of those things we can slide back so quickly. After like, 100 years of women fighting for their rights, we can end up losing that very, very quickly in society. That's just one of many examples I know all the D, E and I stuff that's going on, and I. I mean, it's just heartbreaking, the extent of that pendulum slapping back the other way, so hard when we need to have a balance, and you know, the right balance, because the answer is never black and white, black or white, the answer is always some shade of gray.   Michael Hingson ** 25:20 How do we get people to not backslide? And I know that's a really tough question, and maybe there's no there, there very well may not really be an easy answer to that, but I'm just curious what your thoughts are.   Dr. Laura Hambley Lovett ** 25:37 That's a great question. Michael, I would envision almost ski poles or hiking poles. It's being grounded into the earth. It's being grounded into what are the roots of my values? What are my the values that we hold dear as human beings and as society, and sticking to those values, and, you know, pushing in to the earth to hold those values and stand up for those values, which I know is easier said than done in certain climates and certain contexts. And I mean, but I think it's really important to stand strong for what our values   Michael Hingson ** 26:20 are, yeah, I think that's really it. It comes down to values and principles. I know the late president, Jimmy Carter once said that we must adjust to changing times while holding to unwavering principles. And it seems to me you were talking about this being a tricky world. I thought that was an interesting way to express it. But I'm wondering if we're seeing all too many people not even holding to the unwavering principles, the sacrificing principles for political expediency and other things, yeah,   Dr. Laura Hambley Lovett ** 26:53 yes, exactly. And we know about values that sometimes values clash, right? So you might have a value that you want to have a lot of money and be financially, you know, successful, yet you have the value of work life balance and you want a lot of time off and and sometimes those values can clash, and sometimes we need to make decisions in our lives about what value takes precedence at this time in our life. But I think what you're right is that there's a lot of fear out there right now, and when the fear happens, you can lose sight of why those values are important to you for more of a shorter term, quick gain to get rid of the fear, because fear is uncertain and painful for humans.   Michael Hingson ** 27:44 Well, I wrote live like a guide dog, which is the latest book that was, that was published in August of last year, and it's all about learning to control fear, really. And the reality is, and what I say in the book, essentially is, look, fear is with us. I'm not going to say you shouldn't be afraid and that you can live without fear, but what you can do is learn to control fear, and you have the choice of learning how you deal with fear and what you allow fear to do to you. And so, for example, in my case, on September 11, that fear was a very powerful tool to help keep me focused going down the stairs and dealing with the whole day. And I think that's really the the issue is that fear is is something that that all too many people just have, and they let it overwhelm them, or, as I put it, blind them, and the result of that is that they can't make decisions, they can't move on. And so many things are happening in our world today that are fomenting that fear, and we're not learning how to deal with it, which is so unfortunate.   Dr. Laura Hambley Lovett ** 29:02 Yeah, you're right. And I back to your World Trade Center. So you were on, was it 778? 78 oh, my god, yeah. So to me, that must have been the scariest moment of your life.   Michael Hingson ** 29:17 I'm missing in a in a sense, no only until later, because none of us knew what was happening when the plane hit the building, which it did on the other side of the building from me and 1000s of others, and it hit above where we were. So going down the stairs, none of us knew what happened, because nobody saw it. And as I point out, Superman and X ray vision are fiction. So the reality is, it had nothing to do with blindness. The fact is, none of us knew going down the stairs. We figured out a plane hit the building because we smelled something that I eventually identified as burning jet fuel fumes, because I smell it every time I went to an airport. But we didn't know what happened. And. And and in a sense, that probably was a good thing for most people. Frankly, I would rather have known, and I can, I can say this, thinking about it a lot as I do, I would rather have known what happened, because it would have affected perhaps some of the decisions that I made later. If I had known that the buildings had been struck and there was a likelihood that they would collapse. I also know that I wouldn't have panicked, but I like information, and it's something that I use as a tool. But the fact is that we didn't know that. And so in a sense, although we were certainly worried about what was going on, and we knew that there was fire above us, we didn't know what it was all about.   Dr. Laura Hambley Lovett ** 30:41 Wow. And I would say, so glad you got out of there. I Yeah, what a horrific experience. I was up there the year before it happened. And I think being up there, you can just sense the the height of it and the extent of it, and then seeing ground zero after and then going there with my son last June and seeing the new world trade, it was just really, I really resonate with your or not resonate, but admire your experience that you got out of there the way you did, and thank goodness you're still in this world. Michael,   Michael Hingson ** 31:17 it's a weird experience having been back, also now, going through the museum and being up in the new tower, trying to equate where I was on September 11 and where things were with what it became when it was all rebuilt. There's no easy reference point, although I did some of the traveling around the area with someone who knew what the World Trade Center was like before September 11. And so they were able to say, Okay, you're standing in such and such a place, so you're standing right below where Tower One was. And then I could kind of put some reference points to it, but it was totally different. Needless to say,   Dr. Laura Hambley Lovett ** 32:05 Yeah, no kidding, but I think the fear that you go through during a disaster, right, is immediate like so the fight flight response is activated immediately, and you're, you're put into this almost state of flow. I call it a state where you time just is irrelevant. You're just putting one foot ahead of the other, right, right, right? Whereas the fear that society is going through right now, I think, is a projecting out into the future fear. It's not surviving this moment. It's more about I want to make sure I have enough money in the future, and I want to make sure I have safety in the future, or whatever it is, and you're projecting out, and you're living in the future, and you're worrying about the future, you're not living in the present, and it makes people kind of go crazy in the end, with anxiety, because we're not meant to be constantly worried about the Future. The only thing we can control is today and what we put into place for a better tomorrow, but fearing tomorrow and living in anxiety is so unhealthy for the human spirit,   Michael Hingson ** 33:13 and yet that's what people do, and it's one of the things we talk about and live like a guide dog. Worry about what you can control and don't worry about the rest. And you know, we spend so much time dealing with what if, what if this happens? What if that happens? And all that does, really is create fear in us, rather than us learning, okay, I don't really have control over that. I can be worried about the amount of money I have, but the real question is, what am I going to do about it today? And I know one of the lessons I really learned from my wife, Karen, we had some times when when we had significant debt for a variety of reasons, but like over the last few years of her life, we had enough of an income from speaking and the other things that I was doing that she worked really hard to pay down credit card bills that we had. And when she passed, most all of that was accomplished, and I was, I don't know whether she thought about it. She probably did, although she never got to the point of being able to deal with it, but one of the things that I quickly did was set up with every credit card company that we use paying off each bill each month, so we don't accrue credit, and so every credit card gets paid off, because now the expenses are pretty predictable, and so we won't be in that situation as long as I continue to allow things to get paid off every month and things like that. But she was the one that that put all that in motion, and it was something she took very, very seriously, trying to make sure. It. She brought everything down. She didn't really worry so much about the future. Is, what can I do today? And what is it that my goal is? Well, my goal is to get the cards paid off. I can do this much today and the next month. I can do this much today, which, which I thought was a great way and a very positive way to look at it. She was very methodical, but she wasn't panicky.   Dr. Laura Hambley Lovett ** 35:24 Mm, hmm. No, I like that, because panic gets us nowhere. It just It ruins today and it doesn't help tomorrow, right? Same with regret, regret you can't undo yesterday, and living in regret, guilt, living in the past is just an unhealthy place to be as well, unless we're just taking the learnings and the nuggets from the past. That's the only reason we need the past is to learn from it. You   Michael Hingson ** 35:52 have to learn from it and then let it go, because it's not going to do any good to continue to dwell on it.   Dr. Laura Hambley Lovett ** 35:57 Yeah, exactly.   Michael Hingson ** 36:00 Well, so you, you, you see so many things happening in this world. How do we deal with all of it, with all the trickiness and things that you're talking about?   Dr. Laura Hambley Lovett ** 36:10 Do you like that word, tricky? I like it. That's a weird word.   Michael Hingson ** 36:14 Well, I think it's, it's a different word, but I like it, it, it's a word that I think, personally, becomes non confrontive, but accurate in its descriptions. It is tricky, but, you know, we can, we can describe things in so many ways, but it's better to do it in a way that isn't judgmental, because that evokes attitudes that we don't need to have.   Dr. Laura Hambley Lovett ** 36:38 Yeah, if I use the word scary or terrible, or, I think those words are, yeah, just more anxiety provoking. Tricky can be tricky. Can be bad, tricky can be a challenge,   Michael Hingson ** 36:52 right? Like a puppy, unpredictable, or, you know, so many things, but it isn't, it isn't such a bad thing. I like that.   Dr. Laura Hambley Lovett ** 37:03 How do we navigate a tricky world? Well, we we need to focus on today. We need to focus on the things that we can control today, physically, mentally, emotionally, socially and spiritually, the five different arenas of our life and on any given day, we need to be paying attention to those arenas of our life and how are they doing. Are we healthy physically? Are we getting around and moving our bodies? Are we listening to our bodies and our bodies needs? Are we putting food into our bodies, and are we watching what we drink and consume that could be harming our bodies, and how does it make us feel? And are we getting enough sleep? I think sleep is a huge issue for a lot of people in these anxiety provoking times.   Michael Hingson ** 37:56 Well, I think, I think that's very accurate. The question is, how do we learn to do that? How do we teach ourselves?   Dr. Laura Hambley Lovett ** 38:07 How do we learn to do all that   Michael Hingson ** 38:09 stuff? How do we how do we learn to deal with the things that come up, rather than letting them all threaten us and scare us?   Dr. Laura Hambley Lovett ** 38:20 Oh, that's a big question. I think that well, the whole the five spheres, right? So if you're taking care of your physical health and you're making that a priority, and some people really struggle with that, and they need a buddy system, or they need professional helpers, right, like a coach or a trainer or a psychologist like me, or whatever it is that they need the extra supports in place, but the physical super important, the making sure that we are socially healthy and connectedness is more important than ever. Feeling connected to our tribe, whatever that is, our close friends. You know, whether we have family that we would consider friends, right? Who in our team is helpful to us and trusted allies, and if we can have the fingers of one hand with close people that we trust in our lives, that's that's great, right? It doesn't have to be 100 people, right? It can be a handful, over your lifetime of true allies to walk through this world together.   Michael Hingson ** 39:26 One of the things that I've talked about it a bit on this podcast, but I I love the the concept that I think I've come up with is I used to always say I'm my own worst critic, and I said that because I love to record, and I learned the value of recording speeches, even going back to when I worked at campus radio station at kuci in Irvine campus radio station, I would listen to my show, and I kind of forced all the On Air personalities. 90s to listen to their own shows by arranging for their shows to be recorded, because they wouldn't do it themselves. And then I sent recordings home with them and said, You've got to listen to this. You will be better for it. And they resisted it and resisted it, but when they did it, it was amazing how much they improved. But I as I recorded my talks, becoming a public speaker, and working through it, I kept saying, I record them because I'm my own worst critic. I'm going to pick on me harder than anyone else can. And it was only in the last couple of years because I heard a comment in something that I that I read actually, that said the only person who can really teach you anything is you. Other people can present information, they can give you data, but you are really the only one who can truly teach you. And I realized that it was better to say I'm my own best teacher than my own worst critic, because it changes the whole direction of my thought, but it also drops a lot of the fear of listening or doing the thing that I was my own worst critic   Dr. Laura Hambley Lovett ** 41:10 about. I love that, Michael. I think that's genius. I'm my own best teacher, not my own worst critic,   Michael Hingson ** 41:19 right? It's it's positive, it's also true, and it puts a whole different spin on it, because one of the things that we talk about and live like a guide dog a lot is that ultimately, and all the things that you say are very true, but ultimately, each of us has to take the time to synthesize and think about the challenges that we face, the problems that we faced. What happened today that didn't work well, and I don't use the word fail, because I think that also doesn't help the process. But rather, we expected something to happen. It didn't. It didn't go well. What do we do about it? And that ultimately, taking time at the end of every day, for example, to do self analysis helps a lot, and the result of that is that we learn, and we learn to listen to our own inner mind to help us with that   Dr. Laura Hambley Lovett ** 42:17 exactly, I think that self insight is missing in a lot of us, we're not taking the time to be still and to listen to the voice within and to listen to what we are thinking and feeling internally, because we're go, go, go, go, go, and then when we're sitting still, you know what we're doing, we're on our phones,   Michael Hingson ** 42:41 and That's why I say at the end of the day, when you're getting ready, you're in bed, you're falling asleep. Take the time. It doesn't take a long time to get your mind going down that road. And then, of course, a lot happens when you're asleep, because you think about it   Dr. Laura Hambley Lovett ** 43:01 exactly. And you know, I've got to say, however spirituality is defined, I think that that is a key element in conquering this level of anxiety in society. The anxiety in society needs to be conquered by a feeling of greater meaning and purpose and connectedness in the human race, because we're all one race, the human race, in the end of the day, and all these divisions and silos and what's happening with our great you know, next door neighbors to each other, the US and Canada. It's the way that Canada is being treated is not not good. It's not the way you would treat a neighbor and a beloved neighbor that's there for you. In the end of the day, there's fires in California. We're sending our best fire crews over. You know, World War One, where my grandpa thought and Vimy Ridge, Americans were struggling. British could not take Vimy. It was the Canadians that came and, you know, got Vimy and conquered the horrific situation there. But in the end, we're all allies, and we're all in it together. And it's a tricky, tricky world,   Michael Hingson ** 44:11 yeah, and it goes both ways. I mean, there's so many ways the United States has also helped. So you're not, yeah, you're not really in favor of Canada being the 51st state, huh?   Dr. Laura Hambley Lovett ** 44:26 You know, no, yeah, I love America. I mean, I have a lot of great friends in America and people I adore, but I think Canada is its own unique entity, and the US has been a great ally in a lot of ways, and we're in it together, right, right? I mean, really in it together, and we need to stay as allies. And as soon as you start putting up a fence and throwing rocks over the fence to each other, it just creates such a feud and an unnecessary feud, yeah.   Michael Hingson ** 44:55 Well, very much so. And it is so unfortunate to see. It happening. And as you said, I think you put it very well. It's all about we're friends and friends. Don't treat friends in this way. But that is, that is, unfortunately, what we're seeing. I know I've been looking, and I constantly look for speaking opportunities, home, and I've sent emails to some places in Canada, and a few people have been honest enough to say, you know, we love what you do. We love your story. But right now, with what's going on between the United States and Canada, we wouldn't dare bring you to Canada, and while perhaps I could help by speaking and easing some of that a little bit. I also appreciate what they're saying, and I've said that to them and say, I understand, but this too shall pass. And so please, let's stay in touch, but I understand. And you know, that's all one can do.   Dr. Laura Hambley Lovett ** 46:01 Yeah, and it, it too shall pass. I mean, it's just all and then anxiety takes over and it gets in the way of logic. Michael Hingston would, hingson would be our best speaker for this option, but the optics of it might get us into trouble, and they just get all wound up about it. And I you know, in the end of the day this, this will pass, but it's very difficult time, and we need to say, Okay, we can't control what's going to happen with tariffs or next month or whatever, but we can control today. And, yeah, I just went on a walk by the river. It was beautiful, and it was just so fulfilling to my soul to be outside. And that's what I could control the day   Michael Hingson ** 46:41 that's right? And that walk by the river and that being outside and having a little bit of time to reflect has to help reduce fear and stress.   Dr. Laura Hambley Lovett ** 46:54 It does it very much, does   Michael Hingson ** 46:58 and and isn't that something that that more people should do, even if you're working in the office all day, it would seem like it would be helpful for people to take at least some time to step away mentally and relax, which would help drop some of the fear and the stress that they face. Anyway,   Dr. Laura Hambley Lovett ** 47:20 100% and I am at my office downtown today, and I can see the river right now from my window. And there's research evidence that when you can see water flowing and you can see trees, it really makes a difference to your mental health. So this office is very intentional for me, having the windows having the bright light very intentional.   Michael Hingson ** 47:44 I have a recording that I listen to every day for about 15 minutes, and it includes ocean sounds, and that is so soothing and just helps put so many things in perspective. Now it's not quite the same as sitting at the ocean and hearing the ocean sounds, but it's close enough that it works.   Dr. Laura Hambley Lovett ** 48:06 That's beautiful. And you're going to come on to my podcast and we're going to talk a lot more about your story, and that'll be really great.   Michael Hingson ** 48:14 We're doing that in May.   48:16 Yeah,   Michael Hingson ** 48:17 absolutely, and I'm looking forward to it. Well, how did you get involved in doing a podcast? What got you started down that road? Oh, your tricky podcast. Yeah.   Dr. Laura Hambley Lovett ** 48:32 So I was running my company. So I have a company of psychologists in Canada, and we operate across the country, and we do two things really, really well. One is helping people navigate their careers at all ages and stages and make find fulfilling career directions. And then our other thing we do well is helping organizations, helping be healthier places to work, so building better leaders, helping create better cultures in organizations. So that's what we do, and we have. I've been running that for 16 years so my own firm, and at the same time, I always wanted a podcast, and it was 2020, and I said, Okay, I'm turning 45 years old. For my birthday gift to myself, I'm going to start a podcast. And I said, Does anyone else on the team want to co host, and we'll share the responsibilities of it, and we could even alternate hosting. No, no, no, no, no, no one else was interested, which is fine, I was interested. So I said, this is going to be, Dr Laura, then this podcast, I'm going to call it. Dr Laura, where work meets life. So the podcast is where work meets life, and then I'm Dr Laura, Canada's. Dr Laura,   Michael Hingson ** 49:41 yeah, I was gonna say there we've got lots of dr, Laura's at least two not to be   Dr. Laura Hambley Lovett ** 49:44 mixed up with your radio. One not to be mixed up completely different, right, in approach and style and values. And so I took on that started the podcast as the labor of love, and said, I'm going to talk about three. Three things, helping people thrive in their careers, helping people thrive in their lives, and helping organizations to thrive. And then, oh yeah, I'll throw in some episodes around advocating for a better world. And then the feedback I got was that's a lot of lanes to be in, Laura, right? That is a lot of lanes. And I said, Yeah, but the commonality is the intersection of work and life, and I want to have enough variety that it's stuff that I'm genuinely curious to learn, and it's guests that I'm curious to learn from, as well as my own musings on certain topics. And so that's what's happened. So it's it's 111 episodes in I just recorded 111 that's cool, yeah. So it's every two weeks, so it's not as often as some podcasts, but every episode is full of golden nuggets and wisdom, and it's been a journey and a labor of love. And I do it for the joy of it. I don't do it as a, you know, it's not really a business thing. It's led to great connections. But I don't do it to make money, and, in fact, it costs me money, but I do it to make a difference in the tricky world,   Michael Hingson ** 51:11 right? Well, but at the same time, you get to learn a lot. You get to meet people, and that's really what it's all about anyway.   Dr. Laura Hambley Lovett ** 51:21 Oh, I've met some incredible people like you through doing it, Michael and like my mentor, Sy Wakeman, who wrote the book no ego that's behind me in my office, and who's just a prolific speaker and researcher on drama and ego in the workplace. And you know, I've, I've met gurus from around the world on different topics. It's been fabulous,   Michael Hingson ** 51:47 and that is so cool. Well, and you, you've written some books. Tell us about your books, and by the way, by the way, I would appreciate it if you would email me photos of book covers, because I want to put those in the show notes.   Dr. Laura Hambley Lovett ** 52:03 Oh, okay, I'm going to start with my current book that it actually, I just submitted my manuscript the other day, and it's, it's about toxic bosses, and how we can navigate and exit and recover from a toxic boss. And I saw this as a huge problem in the last couple of years, across different workplaces, across different people, almost everyone I met either had experienced it or had a loved one experience a toxic boss. And so I said, What is a toxic boss? First of all, how is this defined, and what does the research say? Because I'm always looking at, well, what the research says? And wait a minute, there's not a lot of research in North America. I'm an adjunct professor of psychology. I have a team of students. I can do research on this. I'm going to get to the bottom of toxic bosses post pandemic. What? What are toxic bosses? What are the damage they're inflicting on people, how do they come across, and what do we do about it? And then, how do we heal and recover? Because it's a form of trauma. So that's what I've been heavily immersed in, heavily immersed in. And the book is going to really help a lot of humans. It really is. So that's my passion right now is that book and getting it out into the world in January 2026, it's going to be   Michael Hingson ** 53:27 published. What's it called? Do you have a title   Dr. Laura Hambley Lovett ** 53:30 yet? I do, but I'm not really okay title officially yet, because it's just being with my publisher and editor, and I just don't want to say it until actually, Michael, I have the cover so it's going through cover design. I have a US publisher, and it's going through cover design, and that's so important to me, the visual of this, and then I'll share the I'll do a cover reveal. Good for you, yeah, and this is important to me, and I think it's timely, and I really differentiate what's a difficult boss versus a toxic boss, because there's a lot of difficult bosses, but I don't want to mix up difficult from toxic, because I think we need to understand the difference, and we need to help difficult bosses become better. We need to help toxic bosses not to do their damage and organizations to deal with them. And it's just there's so many different legs to this project. I'll be doing it for years.   Michael Hingson ** 54:24 So what's the difference between difficult and toxic? Or can you talk about that?   Dr. Laura Hambley Lovett ** 54:29 Yeah, I can talk about, I mean, some of the differences difficult bosses are frustrating, annoying. They can be poor communicators, bad delegators. They can even micromanage sometimes, and micromanagement is a common thing in new leaders, common issue. But the difference is that they the difficult boss doesn't cause psychological harm to you. They don't cause psychological and physical harm to you. They're not. Malicious in their intent. They're just kind of bumbling, right? They're just bumbling unintentionally. It's unintentional. The toxic boss is manipulative, dishonest, narcissistic. They can gaslight, they can abuse, they can harass, all these things that are intentional. Negative energy that inflicts psychological and or physical harm.   Michael Hingson ** 55:27 And I suspect you would say their actions are deliberate for the most part, for the most part, at   Dr. Laura Hambley Lovett ** 55:35 least, yeah. And that's a whole Yeah, yeah. I would say whether they're deliberate or not, it's the impact that matters. And the impact is deep psychological hurt and pain, which is, and we know the Psych and the body are related, and it often turns into physical. So my research participants, you know, lots of issues. There's there's research. Cardiovascular is impacted by toxic bosses. Your mental health is your your heart rate, your your digestion, your gut. I mean, all of it's connected. When you have a toxic Boss,   Michael Hingson ** 56:09 what usually creates a toxic boss? It has to come from somewhere   Dr. Laura Hambley Lovett ** 56:18 that stems back to childhood. Typically got it. And we get into a whole you know about childhood trauma, right? Big T trauma and little T trauma. Little T trauma are almost death by 1000 paper cuts. It's all the little traumas that you know you you went through, if they're unaddressed, if they're unaddressed, big T trauma is you were sexually assaulted, or you were physically abused, or you went through a war and you had to escape the war torn country, or those sorts of things I call big T and I've learned this from other researchers. Little Ts are like this. You know, maybe microaggressions, maybe being teased, maybe being you know, these things that add up over time and affect your self confidence. And if you don't deal with the little Ts, they can cause harm in adulthood as well. And so that's what, depending on what went on earlier, whether you dealt with that or not, can make you come across into adulthood as a narcissist, for example,   Michael Hingson ** 57:21 right? Well, you've written some other books also, haven't   Dr. Laura Hambley Lovett ** 57:25 you? Oh, yeah, so let's cheer this conversation up. I wrote two psychological thrillers. I am mad. I have an active imagination. I thought, what if someone got kidnapped by a billionaire, multi billionaire ex boyfriend who was your high school sweetheart, but it was 10 years later, and they created a perfect life for you, a perfect life for you, in a perfect world for you. What would that be like? So it's all about navigating that situation. So I have a strong female protagonist, so it's called losing cadence. And then I wrote a sequel, because my readers loved it so much, and it ended on a Hollywood cliffhanger. So then I wrote the sequel that takes place 12 years later, and I have a producing partner in in Hollywood, and we're pitching it for a TV series filmed as a three season, three seasons of episodes, and potentially more, because it's a really interesting story that has you at the edge of your seat at every episode.   Michael Hingson ** 58:28 Have those books been converted to audio? Also?   Dr. Laura Hambley Lovett ** 58:33 No, no, I never converted them to audio. But I should. I should.   Michael Hingson ** 58:37 You should, you should. Did you publish them? Or did you have a publisher? I   Dr. Laura Hambley Lovett ** 58:41 published these ones. Yeah, a decade ago, a decade ago,   Michael Hingson ** 58:45 it has gotten easier, apparently, to make books available on Audible, whether you read them or you get somebody else to do it, the process isn't what it used to be. So might be something to look at. That'd be kind of fun.   Dr. Laura Hambley Lovett ** 59:00 I think so. And I'll be doing that for my toxic boss book. Anyway, Michael, so I'm going to learn the ropes, and then I could do it for losing cadence and finding Sophie,   Michael Hingson ** 59:09 you'd find probably a lot of interested people who would love to have them in audio, because people running around, jogging and all that, love to listen to things, and they listen to podcasts, yours and mine. But I think also audio books are one way that people get entertained when they're doing other things. So yeah, I advocate for it. And of course, all of us who are blind would love it as well. Of   Dr. Laura Hambley Lovett ** 59:34 course, of course, I just it's on my mind. It's and I'm going to manifest doing that at some point.   Michael Hingson ** 59:41 Well, I want to thank you for being here. This has been absolutely a heck of a lot of fun, and we'll have to do it again. We'll do it in May, and we may just have to have a second episode going forward. We'll see how it goes. But I'm looking forward to being on the your podcast in May, and definitely send me a. The book covers for the the two books that you have out, because I'd like to make sure that we put those in the show notes for the podcast. But if people want to reach out to you, learn more about you, maybe learn what you do and see how you can work with them. How do they do that?   Dr. Laura Hambley Lovett ** 1:00:14 Sure, that's a great question. So triple w.dr, Laura all is one word, D R, L, A, u, r, a, dot live. So Dr, Laura dot live is my website, and then you'll find where work meets life on all the podcast platforms. You'll find me a lot on LinkedIn as Dr Laura Hambley, love it, so I love LinkedIn, but I'm also on all the platforms, and I just love connecting with people. I share a lot of videos and audio and articles, and I'm always producing things that I think will help people and help organizations.   Michael Hingson ** 1:00:52 Well, cool. Well, I hope people will reach out. And speaking of reaching out, I'd love to hear what you all think of our episode today. So please feel free to email me at Michael H I M, I C H, A, E, L, H i at accessibe, A, C, C, E, S, S i b, e.com, or go to our podcast page, which is w, w, w, dot Michael hingson.com/podcast and Michael hingson is m, I C H, A, E, L, H i N, G, s o n.com/podcast, wherever you're listening, please give us a five star rating. We value that. If you don't give us a five star rating, I won't tell Alamo, my guy dog, and so you'll be safe. But we really do appreciate you giving us great ratings. We'd love to hear your thoughts. If any of you know of anyone else who ought to be a guest on our podcast, or if you want to be a guest, and of course, Laura, if you know some folks, we are always looking for more people to come on unstoppable mindset. So please feel free to let me know about that. Introduce us. We're always looking for more people and more interesting stories to tell. So we hope that that you'll do that. But I want to thank but I want to thank you again for coming on today. This has been fun,   Dr. Laura Hambley Lovett ** 1:02:07 definitely, and I really admire you, Michael, and I can't wait to have you on where work meets life.   **Michael Hingson ** 1:02:18 You have been listening to the Unstoppable Mindset podcast. Thanks for dropping by. I hope that you'll join us again next week, and in future weeks for upcoming episodes. To subscribe to our podcast and to learn about upcoming episodes, please visit www dot Michael hingson.com slash podcast. Michael Hingson is spelled m i c h a e l h i n g s o n. While you're on the site., please use the form there to recommend people who we ought to interview in upcoming editions of the show. And also, we ask you and urge you to invite your friends to join us in the future. If you know of any one or any organization needing a speaker for an event, please email me at speaker at Michael hingson.com. I appreciate it very much. To learn more about the concept of blinded by fear, please visit www dot Michael hingson.com forward slash blinded by fear and while you're there, feel free to pick up a copy of my free eBook entitled blinded by fear. The unstoppable mindset podcast is provided by access cast an initiative of accessiBe and is sponsored by accessiBe. Please visit www.accessibe.com . AccessiBe is spelled a c c e s s i b e. There you can learn all about how you can make your website inclusive for all persons with disabilities and how you can help make the internet fully inclusive by 2025. Thanks again for Listening. Please come back and visit us again next week.

N347 - Estudo Optimal, o maior estudo testando o controle intensivo de PA no DM2 e alto risco cardiovascular - Marcio Krakauer e Otávio Berwanger by SBD

N349 - DOENÇA CARDIOVASCULAR E DIABETES – Fernando Valente e Otávio Berwanger by SBD

Cardiovascular disease has been among the leading causes of death in America for decades. It's clear that optimizing the human heart is critical for longevity – but are there really sustainable ways to achieve this? In this episode, Mark Young joins us to discuss how isometric exercise can improve cardiovascular health and overall wellness.  Mark Young is a serial entrepreneur, health tech innovator, and marketing expert with a passion for functional fitness. He serves as CEO of Ryze Agency, a Florida-based marketing firm that helps brands grow through strategic storytelling and data-driven marketing.  Always eager to inspire action, Mark leads eight high-impact ventures spanning advertising, retail distribution, out-of-home TV networks, real estate development, angel investing, health and fitness, and professional auto racing. Dive in now to discover: The benefits of making non-pharmaceutical decisions. The link between isometrics and blood pressure. How isometric exercise differs from other forms of exercise. What happens when blood flow is increased in the body.   Are you ready to take control of your heart health and unlock a stronger, longer-lasting version of yourself? Hit play now! Stay connected with Mark's work by visiting his website or following him on Instagram @themarkyoung. And to learn more about how cardiovascular conditioning is achieved with isometric exercise, www.zona.com should be your first stop! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

This week, Dr. Prather talks about how Aerobic Exercise and External CounterPulsation (ECP) Therapy are treatments that benefit every patient and all types of Cardiovascular Disease.  In this episode, you'll find out:—Why Dr. Prather calls ECP Therapy and Aerobic Exercise "the panacea for Cardiovascular Disease".—The amount of Aerobic Exercise each person needs to prevent or reverse Cardiovascular Disease.  (And why everyone reading this probably does not measure up!)—The story of how ECP Therapy was designed by Harvard decades ago to do Aerobic Exercise for patients who couldn't even walk across the room without losing their breath.  Plus, how long-distance runners are using ECP to help set new records. —How Dr. Prather called the FDA to ask if it would be OK for him to offer ECP Therapy to his patients and was actually encouraged by them to do this therapy in his office.—The "amazing" safety record of ECP Therapy that has NEVER had a single injury reported in decades of use.—The screening Dr. Prather does on patients prior to ECP Therapy for potential contraindications to ensure patient safety.—Why Cardiologists refer for ECP Therapy after everything else has been tried.  And how everyone who has been referred to Dr. Prather for it has lived.—The conditions that benefit from ECP Therapy, including:  Angina, Congestive Heart Failure, Atherosclerosis, Hypertension, Kidney Disease, Restless Leg Syndrome, Diabetes, Cognitive Brain Function, and Erectile Dysfunction. —How Natalie and John came to see Dr. Prather without an appointment after leaving two different hospitals.  And how Dr. Prather was able to provide John relief from pain that very first day.—The details about Dr. Prather's upcoming free educational seminar, "Diabetes Decoded:  A Holistic Look At Type 1 and Type 2 Diabetes" on Wednesday, June 25th at 6:30 p.m.http://www.TheVoiceOfHealthRadio.com

Why Red Wine Is Good For Your Cardiovascular System | Divij's Den EP138

In this special episode on Fish Oil -  Facts, Fiction, and EPA our host, Dr. Neil Skolnik, will discuss the evidence distinguishing fish oil from EPA (Icosapent ethyl).  This special episode is supported by an independent educational grant from Amarin. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Osborne MD, PhD - Preventive cardiologist and lipidologist, Chief medical officer of Clear Cardio, LLC Selected References: Omega-3 Fatty Acids: STRENGTH trial - JAMA. 2020;324(22):2268-2280 Icosapent Ethyl: JELIS - Lancet. 2007;369(9567):1090-1098 Icosapent Ethyl: REDUCE-IT - N Engl J Med 2019; 380:11-22 ADA Standards of Care: Diabetes Care 2025;48(Supplement_1):S207–S238 https://doi.org/10.2337/dc25-S010 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: Circulation. 2023;148. doi: 10.1161/CIR.0000000000001168  

Dr. Kirk Milhoan is a pediatric cardiologist and senior fellow at the Independent Medical Alliance. He has been treating children with myocarditis and other cardiovascular issues associated with COVID-19 and the COVID-19 vaccines.“Four years later, five years later, I'm seeing this constant and dramatic change in who I'm seeing coming to see me. They're complaining their heart doesn't beat normally. And it beats fast for no reason at all,” says Dr. Milhoan. “Specifically after the second dose of the new platform for the COVID vaccine, we were seeing an increase in myocarditis in children that we've never seen before with any vaccine product in children.”In this episode, we dive into the apparent rise of cardiovascular conditions in children and how to better address and understand them.“We need to return the idea of a patient-doctor relationship,” says Dr. Milhoan. “You're not a consumer. We've made this too marketing-oriented. We need to go back to: ‘I'm a physician who cares for you because I have compassion for you. And because of my compassion, I want you to do well, and I want you to be healthy.'”Views expressed in this video are opinions of the host and the guest and do not necessarily reflect the views of The Epoch Times.

Story at-a-glance Recent data show U.S. maternal mortality rates increased by 27.7% between 2018 and 2022, with one-third of pregnancy-related deaths occurring after the standard six-week postpartum care period Significant disparities exist in maternal death rates by state, race, and ethnicity. American Indian/Alaska Native women face a nearly four times higher risk than white women Cardiovascular disorders are the leading cause of late maternal deaths, followed by cancer and endocrine conditions. Drug and alcohol-related issues and mental or behavioral disorders are also significant contributors U.S. infant mortality also increased by 3% from 2021 to 2022, the first rise in 20 years, with deaths from maternal complications rising 8.6% and newborn bacterial sepsis up 13.7% To reduce maternal mortality risk, track your symptoms after birth, push for care beyond the standard six-week visit, and make informed decisions throughout pregnancy and postpartum

Dr. Maneesha Inamdar is the Director of the Institute for Stem Cell Science and Regenerative Medicine and Professor at Jawaharlal Nehru Centre for Advanced Scientific Research. Her lab uses comparative models, including mice, Drosophila, stem cell lines, and gastruloids, to study developmental biology. She talks about using embryo models to investigate teratogenicity, prioritizing ethnically diverse cell lines, and representing Indian scientists in global discussions.

In this profound episode of Parallax, Dr Ankur Kalra welcomes Dr Pam Taub, Professor of Medicine and Director of Preventive Cardiology at UC San Diego, for an enlightening conversation about integrating spirituality, purpose, and scientific curiosity in cardiovascular practice. Dr Taub shares her unique philosophical foundation, shaped by exposure to diverse religions in South India. This experience fostered her belief that all faiths fundamentally center on being a good person and serving others. She explores how this spiritual perspective transforms medicine from a profession into a sacred calling, where patient interactions become profound privileges that fuel her desire to make meaningful impact beyond individual achievements. The episode highlights Dr Taub's groundbreaking work with POTS (Postural Orthostatic Tachycardia Syndrome), demonstrating how scientific curiosity serves as a spiritual path. Her research journey—from recognizing misdiagnosed conditions to conducting the first clinical trial for ivabradine in POTS—exemplifies how deeper questioning and evidence-based inquiry can transform patient lives on a broader scale. The episode also explores Dr Taub's research on time-restricted eating, connecting modern scientific evidence to fasting practices across many faiths. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

16th ACC 2025: MI and Cardiovascular Risks Associated with Cannabis Use

Dr. Anne Truong is a board-certified physician with over 20 years of clinical experience and a trailblazer in the field of regenerative medicine and men's sexual health. Known for her outside-the-box approach, she helps patients heal the cause of sexual dysfunction—not just mask the symptoms. Through her practice, Dr. Anne has helped countless individuals reclaim their vitality, confidence, and quality of life. Her patients, lovingly called “Vitality Warriors,” trust her integrative, patient-centered methods that blend cutting-edge regenerative therapies with nutrition, hormone balancing, lifestyle support, and deep education.

In this episode, I sit down with Mark Young, CEO of Zona Health, for a conversation that bridges the worlds of health tech, personal growth, and taking radical ownership of your wellbeing.With a career spanning multiple startups and a passion for education, Mark shares how his mission at Zona is not just about product innovation—but empowering people to make informed, sovereign choices about their health. We explore how the Zona Plus supports cardiovascular function, nervous system regulation, and vagal tone in just minutes a day—without medication. Mark also unpacks why so many people outsource their health to insurance companies and governments, and why reclaiming personal responsibility is the real path to vitality.This is a deep dive into the psychology of behavior change, the myth of "rulers" coming to save us, and how micro-decisions shape your long-term outcomes. If you're looking for an honest conversation about sovereignty, science, and self-reliance, this one's for you. Visit zona.com/lukestorey and use code LUKE100 to save $100 off Zona Plus.DISCLAIMER: This podcast is for educational purposes only and not intended for diagnosing or treating illnesses. The hosts disclaim responsibility for any adverse effects from using the information presented. Consult your healthcare provider before using referenced products. This podcast may include paid endorsements.THIS SHOW IS BROUGHT TO YOU BY:LIMITLESS LIVING MD | Book your free consultation today at limitlesslivingmd.com/luke and use code LUKE for 12% off your first order.SUNLIGHTEN | Save up to $600 when you go to lukestorey.com/sunlighten and use code LUKESTOREY in the pricing form.LEELA QUANTUM TECH | Go to lukestorey.com/leelaq and use code LUKE10 for 10% off their product line.NUCALM | Go to nucalm.com and use code LUKE for 15% off!MORE ABOUT THIS EPISODE:(00:00:00) Redefining Radical Generosity(00:05:29) The Physiology of Generosity & the Power of Identity(00:22:21) Identity, Recovery, & the Power of Words(00:31:23) Heart Health, Zona, & Preventative Wake-Up Calls(00:48:04) Zona Demo, Fighter Pilots, & the Real Science Behind Isometric Training(01:07:50) Resetting Your Blood Pressure: Potassium, Endothelium, & the Real Fix(01:30:50) Salt, Science, & Questioning the Narrative(01:40:37) No One's Coming to Save You: Personal Sovereignty & Health Ownership(01:49:55) Zona Protocols, Nervous System Benefits, & the Bona Zona RevelationResources:Website: zona.comWebsite: ryzeagency.comInstagram: instagram.com/themarkyoungInstagram: instagram.com/zonahealthFacebook:

SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases by Citeline

Addressing hypertension at the local and global levels requires using validated tools, following the data, and working with patients and policymakers alike. Guest Yvonne Commodore-Mensah, PhD, MHS, RN, FAAN, FAHA, FPCNA describes strategies for clinical practice as well as legislative advocacy for addressing this global healthcare crisis.Resources: Validated blood pressure monitors: validatebp.org PCNA patient education blood pressure resources: pcna.netHigh Blood Pressure: What you need to know (sheet in English & Spanish)Blood Pressure: How do you measure up? (Booklet in English & Spanish)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With David Duncker, Hannover Heart Rhythm Center, Hannover - Germany, Marco Metra, University of Brescia, Brescia - Italy, Micaela Ebert, Heart Center, University Hospital Dresden, Dresden - Germany, and Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia  During this podcast Marco Metra, David Duncker, Stefan Simovic & Mica Ebert will discuss sudden cardiac death prevention (SCD) in patients with heart failure and reduced ejection fraction (HFrEF). This 2025 EHRA Cardio Talk Keep the rhythm podcast series is supported by ZOLL Cardiac Management Solutions in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsors.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Automated, Standardized, Quantitative Analysis of Cardiovascular Borders on Chest X-Rays Using Deep Learning.

THE CASE Dr Ashville is training to be a family physician and gets a phone call from a disgruntled patient called Jane Brown. She got a message saying “As your Cardiovascular risk is now 10% it is recommended you take a statin medication”. She is a bit cross she didn't get a proper conversation about […]

Circulation 1999;100:2312-2318Background: The CONSENSUS and SOLVD trials established the effectiveness of angiotensin converting enzyme inhibitors (ACEi) in reducing mortality and morbidity in patients with systolic heart failure. Both trials used enalapril with a target dose of 20mg twice a day (max dose) in the CONSENSUS trial and 10mg twice a day (medium dose) in the SOLVD trials. In real-world settings, ACEi are sometimes prescribed at lower doses, likely reflecting concerns about adverse effects or patients' tolerance. It was unclear whether the benefit from low doses of ACEi is comparable to high doses.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.The Assessment of Treatment with Lisinopril and Survival (ATLAS) trial sought to assess the efficacy and safety of low vs high doses of ACE inhibition in patients with systolic heart failure.Patients: Eligible patients had left ventricular ejection fraction of 30% or less and had NYHA class II, III or IV despite treatment with diuretics for two or more months.Patients were excluded if they had any of the following: Acute coronary syndrome or revascularization procedure within 2 months, history of sustained or symptomatic ventricular tachycardia, known intolerance to ACEi, serum creatinine >2.5 mg/dL, or any noncardiac condition that could limit survival.Baseline characteristics: The trial randomized 3,164 patients – 1,596 randomized to the low-dose arm and 1,568 to the high dose arm.The average age of patients was 64 years and 80% were men. The average left ventricular ejection fraction was 23%. Cardiomyopathy was ischemic in 65% of the patients. The NYHA class was II in 16% of the patients, III in 77% and IV in 7%.Data on baseline comorbid conditions were not provided in the main manuscript.Procedures: The study was double blinded. At the beginning of the study, all patients received open-label lisinopril for four weeks to assess who is able to tolerate the drug. Patients who were able to tolerate lisinopril 12.5 mg to15 mg daily for two or more weeks were randomized in a 1:1 ratio to receive low-dose or high-dose ACEi. The target dose of lisinopril in the lose dose group was 2.5 to 5.0mg daily and was 32.5 to 35mg daily in the high dose group.All patients received open-label lisinopril 2.5 to 5mg daily. This dose was selected by the investigator. In addition, patients received up to three 10mg tablets of lisinopril or matching placebo.Endpoints: The primary endpoint was all-cause mortality. Secondary end points included cardiovascular mortality, all-cause hospitalization and cardiovascular hospitalizations.Analysis was performed based on the intention-to-treat principle. The estimated sample size was 3,000 patients. This sample size had 90% power at 5% alpha to detect 15% relative risk difference in the mortality between both treatment groups assuming 19% 1-year mortality in the high dose group.Results: Of the 3,793 patients who entered the initial open-label tolerability phase, 83.4% were randomized. A total of 176/3,793 (4.6%) were withdrawn for possible side effects. The median follow-up time was 46 months.Target doses were achieved in 92.7% of the patients in the low-dose group and 91.3% in the high-dose group. Study medication was discontinued by 30.6% of patients in the low-dose group and 27.2% in the high-dose group.All-cause mortality was not significantly different between both treatment groups (44.9% with low dose vs 42.5% with high dose, HR: 0.92, 95% CI: 0.82 – 1.03; p= 0.128). Cardiovascular mortality was numerically lower in the high dose group but this was not statistically significant (37.2% vs 40.2%, HR: 0.90, 95% CI: 0.81 – 1.01; p= 0.073). All-cause hospitalization was lower in the high dose group (3,819 hospitalizations vs 4,397; p= 0.021). Hospitalizations for cardiac causes and hospitalizations for heart failure were also lower in the high dose group (2,456 vs 2,923; p= 0.05) and (1,199 vs 1,576; p= 0.002), respectively.Patients in the high-dose group experienced more dizziness (19% vs 12%), more hypotension (11% vs 7%), more worsening renal function (10% vs 7%), and more hyperkalemia (6% vs 4%), but reported less cough (11% vs 13%) and had less hypokalemia (1% vs 3%).There were no significant subgroup interactions for the primary outcome.Conclusion: In patients with systolic heart failure, high dose ACE inhibition did not significantly reduce mortality compared to low-dose but it led to significantly less hospitalizations. In this trial of 3,164 patients and with a median follow up of 46 months, there were 578 less hospitalizations in the high dose group.Based on these results, we recommend up-titrating ACEi and use higher doses if tolerated. Although, side effects were more common in the high dose group, these can generally be managed with reducing the dose in the outpatient settings.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

Dr. Sam Tyagi, a vascular surgeon at the UK Gill Heart & Vascular Institute, discusses the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE) device.

Tuesday, May 27-  Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with President Biden's metastatic prostate cancer, why people are questioning when he was actually diagnosed and if there was dishonesty when many were questioning his health while he was still in office. Then, news of the first-ever human bladder transplant takes place in Southern California, good news for migraine sufferers as an already approved migraine medication can stop early-migraine symptoms hours before the headache itself even begins. Next, Dr. Ken sheds light on the dos and don'ts of recovering after a heart attack, and how loneliness affects your mental and physical health. Listener questions close up the conversation with “when is the best time of day to weigh yourself,” and the fact that your weight can vary up to 8 pounds during the day, which is why first thing in the morning, post morning bathroom break but before you've eaten or drank anything, is the best time of day. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

My guest is Dr. Melissa Ilardo, Ph.D., professor of biomedical informatics at the University of Utah. We discuss the interplay between genes and behaviors, including how certain behaviors can improve resilience by changing gene and organ function, as well as natural selection events happening in humans today. We also discuss the immune system–related reasons people find the smells of potential mates attractive—or not. We explore how physical and psychological traits are passed from one generation to the next, and the specific behaviors that can influence gene expression to improve health and performance. Melissa explains her lab's pioneering research on breath-hold training and how activation of the dive reflex through breath holding can significantly improve oxygen availability by changing spleen size and function. We also delve into the medical uses and ethics of gene editing to cure disease in both babies and adults. For those interested in genes and inheritance, human performance, immune system function, and natural selection, this episode illustrates the remarkable interplay between human nature and nurture. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Joovv: https://joovv.com/huberman Eight Sleep: https://eightsleep.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00:00 Melissa Ilardo 00:02:35 Nature vs Nurture, Gene Expression, Eye Color 00:07:06 Sponsors: Joovv & Eight Sleep 00:10:24 Epigenetics, Trauma, Mutations; Hybrid Vigor, Mate Attraction 00:15:47 Globalization; Homo Sapiens, Mating & Evolution; Mutations 00:25:28 Sea Nomads, Bajau & Moken Groups; Free Diving, Dangers & Gasp Reflex 00:32:52 Cultural Traditions, Free Diving & Families; Fishing 00:35:36 Mammalian Dive Reflex, Oxygen, Spleen, Cold Water & Face; Exercise 00:42:43 Sponsors: AG1 & LMNT 00:46:00 Free Diving, Spleen, Thyroid Hormone, Performance Enhancement 00:52:00 Dive Reflex, Immune System; Swimming & Health; Coastal Regions & Genetics 00:55:17 Female Free Divers, Haenyeo, Cold Water, Age, Protein 01:03:20 Human Evolution & Diet, Lactase, Fat 01:05:07 Korean Female Free Divers & Adaptations, Cardiovascular, Pregnancy 01:10:13 Miscarriages & Genetic Selection; Bajau, External Appearance, Mate Selection 01:17:15 Sponsor: Function 01:19:03 Free Diving, Underwater Vision; Super-Performers & Genetics 01:25:01 Cognitive Performance, Autism, Creativity; Genetic Determinism & Mindset 01:36:30 Genetics & Ethics, CRISPR, Embryo Genetic Screening 01:44:36 Admixture, Genetics; Are Humans a Single Species? 01:49:39 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Nessa live, eu conversei com médico cardiologista Dr. Ricardo Ferreira (@ricardoferreira_cardio).Conversamos sobre hiperrespondedores e sobre a relação entre colesterol e doenças cardiovasculares. Abordamos a polêmica em torno do estudo Keto-CTA, sobre o uso de carboidratos para baixar o colesterol e sobre medicamentos. Por fim, a importância da ApoB no risco cardiovascular.

This week we move into the arena of preventive cardiology when we review a recent report from the team at Northwestern and Princeton on the impact of early childhood food insecurity on cardiovascular health of people in young adulthood. How does food insecurity in young childhood impact the cardiac health of adults? Why is most of the impact seen on BMI but not other measures of cardiovascular health. How can food programs that support improved food and nutrition security work to improve long term cardiovascular health of children and adults? Do the benefits of such programs outweight their costs? Dr. Nilay Shah of Northwestern University shares his deep insights into his work and these questions this week.DOI: 10.1001/jamacardio.2025.1062

0:00: Introduction to cardiovascular aging 2:00: How does the cardiovascular system age, and why should we care? 5:56: How to measure cardiovascular aging 8:24: How different types of exercise affects cardiovascular aging 11:30: Exercise recommendations for improving cardiovascular age12:54: How to track cardiovascular improvements without a fitness wearableTo take our free 35-minute Upper Body Build class taught by Dr. Shannon, visit portal.evlofitness.com.

Lancet 1999;353:2001-07Background: Beta-blockers directly reduce cardiac contractility and myocardial oxygen demand. For decades, they were avoided in patients with acute and chronic heart failure over concerns they would facilitate decompensation of the condition. The therapeutic cornerstones of treatment, prior to the modern era of clinical trials, focused on managing symptoms and quality of life with diuretics and inotropic agents like digoxin; however, new paradigms were arising that focused on addressing neurohormonal mechanisms of chronic disease that were over-activated in the failing heart. The first major success came with inhibition of the renin angiotensin aldosterone system with angiotensin converting enzyme inhibitors whose effect on mortality for patients with mild and severe forms of chronic heart failure were demonstrated in the V-HEFT II, CONSENSUS, and SOLVD trials. Additional benefits were demonstrated with the mineralocorticoid receptor antagonist spironolactone in the RALES trial. These drug classes primarily work by reducing afterload and volume retention. Appreciating why they work for improving cardiac performance and managing symptoms in heart failure patients is straightforward when we consider the major factors that effect cardiac stroke volume - preload, afterload and contractility; however, it is also noteworthy the effects these agents have on sudden death. How beta-blockade benefits the failing heart is less obvious (outside prevention of sudden death). Mechanistic studies in patients with chronic heart failure have consistently shown that when beta blockers are used for more than 1 month, left ventricular function improves. Beta blocker therapy appears to restore the density of beta-adrenergic receptors after they have been downregulated by the chronic overactivity of the sympathetic nervous system. The first major placebo-controlled RCT to demonstrate a mortality benefit used the non-selective beta blocker carvedilol. The trial was small and not originally designed to test mortality and was stopped early without clearly predefined stopping rules. Furthermore, 8% of total patients selected for participation in the trial were excluded prior to randomization after a 2 week, open-label run-in phase with the study drug, which saw 2% of all patients experience worsening heart failure or death representing 24 patients (the difference in total deaths between groups was 9 when the trial was stopped). The Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) was the first large scale trial designed to test the hypothesis that beta-blockade with metoprolol controlled/extended release (CR/XL) added to optimum medical therapy reduces mortality in patients with chronic systolic heart failure.Patients: Patients were recruited from 313 sites in 13 European countries and the United States. Eligible patients were men and women between the age of 40 to 80 years with symptomatic heart failure (NYHA class II-IV) for >/= 3 months before randomization. They had to be on a diuretic and ACE inhibitor for at least 2 weeks. Other drugs, including digoxin, could also be used. Patients also had to have an EF of /=68 beats per minute.Patients were excluded if: they had an MI or unstable angina within 28 days; had an indication or contraindication for treatment with beta-blocker; beta blockade within 6 weeks; heart failure due to systemic disease (i.e., amyloidosis) or alcohol abuse; scheduled or performed cardiac transplant; an ICD; procedures such as CABG or PCI planned or performed in the past 4 months; 2nd or 3rd degree AV block unless a pacemaker was present; unstable or decompensated heart failure defined by pulmonary edema or hypoperfusion or supine systolic BP 25% deviation of the number of observed versus expected consumed placebo tablets during the run-in period.Baseline characteristics: The mean age of patients was 64 years and approximately 78% were male. Slightly more than 30% of patients were above the age of 70. The average EF was 28%. The average SBP was 130 mmHg and heart rate was 82 bpm. Most patients had mild to moderate heart failure, with 41% in NYHA Class II, 56% in Class III, and only 3% in Class IV. Ischemic cardiomyopathy accounted for 65% of cases and nonischemic causes accounted for 35%. Most patients were on an ACE inhibitor or ARB (95%) and diuretic (90%). Digoxin was used in 63%. Trial procedures: Prior to randomization, the study was preceded by a single-blind, 2-week placebo run-in period. Patients meeting eligibility were then randomized to placebo or metoprolol CR/XL. The starting dose of placebo or metoprolol CR/XL was 12.5 mg daily for patients in NYHA class III or IV and 25 mg daily for patients in NYHA class II. The dose was doubled every 2 weeks until the target dose of 200 mg daily was reached. Patients were followed every 3 months.Endpoints: The primary outcome was all-cause mortality. It was estimated that 3,200 patients would need to be followed for 2.4 years to detect a 30% relative reduction in mortality based on annual mortality rate of 9.4% in the placebo group. This would achieve at least 80% power with a 2-sided alpha of 0.04. Patients were recruited faster then planned and so the final sample size of 3,991 patients increased the power of the study.The study was monitored by an independent safety committee and predefined stopping rules for efficacy were based on all-cause mortality, done when 25%, 50%, and 75% of expected deaths had occurred. Results: The trial was stopped early after the 2nd preplanned interim analysis when 50% of expected deaths had occurred. The mean duration of follow-up at the time of stopping was 1 year. The mean daily dose of metoprolol CR/XL was 159 mg once daily, with 87% receiving 100 mg or more and 64% receiving the target dose of 200 mg daily. In the placebo group, the corresponding values were 179 mg daily, 91% and 82%. The study drug was discontinued permanently in 14% of patients in the metoprolol group and 15% in the placebo group. Six months after randomization, heart rate decreased by 14 bpm in the metoprolol group compared to only 3 bpm in the placebo group. Systolic blood pressure decreased less in the metoprolol group (-2.1 vs 3.5 mmHg).Compared to placebo, metoprolol significantly reduced all-cause mortality (7.3% vs 10.8%; RR 0.66; 95% CI 0.53—0.81). Cardiovascular mortality accounted for 91% of all deaths; with sudden death accounting for 58% and death from worsening heart failure accounting for 24% of all deaths. All 3 of these causes of death were significantly reduced by metoprolol. The relative and absolute effects on death were greatest for patients with NYHA class III heart failure.Conclusions: In this trial of stable patients with mild to moderate chronic systolic heart failure, who were optimized on an ACEi or ARB and diuretic, metoprolol CR/XL significantly reduced all-cause mortality. Approximately 30 patients would need to be treated with metoprolol compared to placebo for 1 year to prevent 1 death. This trial represents a significant win for beta blockade in patients with chronic systolic heart failure. While the NNT in this trial is slightly higher than in SOLVD, it is important to appreciate that follow-up time in SOLVD was more than 3x longer. Limitations to external validity in this trial include the run-in period and stringent inclusion and exclusion criteria. Our enthusiasm is also tempered by early stopping, which has been found to be associated with false positive or exaggerated results but this concern is mitigated to some extent in this trial because the rules for early stopping were clearly defined in the protocol.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

In this episode, Westchester Talk Radio host Bob Marrone interviews Dr. Arnar Geirsson, Director of the Cardiovascular Institute and the Surgical Heart Valve Program at NYP Columbia University Irving Medical Center. Dr. Geirsson was one of the honorees at Westchester Magazine's Healthcare Heroes Luncheon on May 15th, 2025, held at Mulino's at Lake Isle Country Club in Eastchester, NY - an event that brought together outstanding individuals who have made remarkable contributions to healthcare in the community. Dr. Geirsson shares insights into advancements in cardiac care, his passion for patient-centered innovation, and what this recognition means to him. Don't miss this conversation celebrating healthcare leadership and excellence. 

In this episode, we review the high-yield topic Supraventricular Tachycardia ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic Digoxin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic Restrictive / Obliterative Cardiomyopathy ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic Aortic Regurgitation ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ventricular Septal Defect (VSD)⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Story at-a-glance Nearly 38% of cardiovascular deaths in Canada are linked to ultraprocessed foods. These products contribute to 96,000 new heart disease cases and 17,400 deaths each year Eating just one additional daily serving of ultraprocessed food raises your risk of obesity by 7%, abdominal fat by 5%, and Type 2 diabetes by 12% Ultraprocessed foods increase cognitive decline risk by 16% and stroke risk by 8%, with the strongest effects seen in Black participants Processed meat products like hot dogs and deli meats are linked to a 43% higher risk of death from neurodegenerative diseases and a 13% higher all-cause mortality risk Even small amounts of ultraprocessed food trigger inflammation, oxidative stress, and mitochondrial dysfunction that accelerate aging and drain your energy daily

In this episode, we review the high-yield topic ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hyperthermia / Heat Injuries⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode, we review the high-yield topic ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ventricular Arrhythmia⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Curious about why CoQ10 is celebrated for heart and energy health? Join Dr. Carrie Lam to discover this vital compound's role in boosting cellular energy and protecting against damage. CoQ10 enhances cardiovascular health, supports energy production, and improves reproductive function. Learn about the best dosages and forms, such as the highly absorbable ubiquinol, and understand potential side effects and interactions with medications. Watch now and subscribe for more essential health tips!Trying to find an integrative medicine or functional medicine doctor who understands what you're going through? Lam Clinic does Telemedicine all over the world and is only a phone call away.1. Educate yourself by visiting our website: www.lamclinic.com2. Call our office at 714-709-8000 to schedule an appointment.FIND US ONLINE HERE:» Website: https://www.lamclinic.com/» Facebook: https://www.facebook.com/lamclinic» Instagram: https://www.instagram.com/lam_clinic/» Tiktok: https://www.tiktok.com/@lamclinic» YouTube: https://www.youtube.com/LAMCLINIC

This week we take a trip back in time to reminisce about what it was like to be a fellow under famed pediatric cardiology pioneer Dr. Alexander S. Nadas. Who better to tell us about what life was like under this giant than 4 present-day giants who lived through it and got their start working for Professor Nadas. Joining the podcast in a live recording from the Boston Children's Cardiology 75th Anniversary Alumni Reunion on May 3rd are Dr. Roberta Williams, Dr. John Barry Keane, Dr. Patricia Rompf and Dr. Thomas Hougen. All have many stories to tell and they share their remembrances and insights in this special episode honoring the memory of the founder of the cardiac program at Boston Children's Hospital - Dr. Nadas. 

Tis the season for itchy, watery eyes and runny, stuffy noses! But you don't have to suffer and there are lots of approaches for comprehensive relief from seasonal allergies. On this episode of Vitality Radio, Jared invites Ben Fuehrer from Utzy Naturals to discuss their Allurtica allergy formula, and how each of its key ingredients work to provide fast relief from allergy symptoms. They also discuss the importance liver health, and lifestyle habits that can help your body handle the season's allergens. Jared also chats with our Homeopathic Consultant, Amanda Kotter, about the synergy between homeopathic remedies that work great alongside Allurtica and on their own for seasonal allergy support!Products:Utzy AllurticaClearLife AllergyAllium CepaOmega-3Precision ProbioticLiverVitalityB5 Pantothenic AcidAdditional Information:#498: Cardiovascular and Metabolic Health Without Drugs with Ben Fuehrer#429: Homeopathic Formulas for Pain, Cold and Flu, and Seasonal Allergies with Marie CamilleTo schedule your Homeopathy Consultation with Amanda:Email Amanda@vitalitynutrition.comCall/Text 801-388-4133Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Story at-a-glance Fatty liver disease affects nearly 25% of adults globally and progresses silently, leading to cirrhosis, heart disease, diabetes, and liver cancer Research shows that fatty liver disease significantly increases mortality risk, especially from endocrine disorders and during the first year after diagnosis Cardiovascular disease ranks as a top threat for people with fatty liver disease, with advanced liver fibrosis substantially increasing the risk of serious adverse events Excessive fructose consumption from processed foods triggers de novo lipogenesis (fat creation) in the liver and promotes insulin resistance, even without alcohol consumption Treatment focuses on addressing root causes through dietary changes, regular physical activity, weight management, muscle-building, and addressing metabolic imbalances like insulin resistance